Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
818 Constipation
clinical trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Parker
mi
from
Parker, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Valley Radiation Oncology
mi
from
Peru, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Peru
mi
from
Peru, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
SWOG
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Heartland Regional Medical Center
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center-South County
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Park Nicollet Clinic - Saint Louis Park
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Regions Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Medical Center - Cherry Hill
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Francis Regional Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Alaska Medical Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Rush - Copley Medical Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute
mi
from
Boise, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Parkland Health Center-Bonne Terre
mi
from
Bonne Terre, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Bozeman Deaconess Hospital
mi
from
Bozeman, MT
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dayton Center for Neurological Disorders
mi
from
Centerville, OH
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Trials, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Constipation Clinical Trial
Understanding Mechanisms of Normal and Disordered Defecation
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
AppleMed Research Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Gastroenterology Research Consultants of Greater Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Indiana Medical Research
mi
from
ELkhart, IN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Medisphere Medical Research Center
mi
from
Evansville, IN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Regional Research Institute
mi
from
Jackson, TN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Center for Digestive and Liver Diseases, Inc.
mi
from
Mexico City, MO
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Prime Care Clinical Research, Inc.
mi
from
Mission Vejo, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Accelovance
mi
from
Peoria, IL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
California Research Foundation
mi
from
San Diego, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Arkansas Gastroenterology
mi
from
Sherwood, AR
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Louisiana Research Center, LLC
mi
from
Shreveport, LA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Spokane Internal Medicine
mi
from
Spokane, WA
Click here to add this to my saved trials
Constipation Clinical Trial
Investigation of Supra Fiber in the Treatment of Adults With Constipation
Status: Enrolling
Updated: 2/22/2011
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Artesia, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Clive, IA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Elizabeth, NJ
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Fresno, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Hawaiian Gardens, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Jackson, TN
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Littleton, CO
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Lodi, NJ
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Norman, OK
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Oakwood, OH
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Orange, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Reno, NV
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Southfield, MI
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Sugarland, TX
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Waterbury, CT
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Wichita, KS
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Sunstone Medical Research, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Dayton Gastroenterology
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
May Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Hilltop Physicians IN / Hightop Medical Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
New Horizons Clinical Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Alpha Clinical Research
mi
from
Clarksville, TN
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Clinical Research Advantage, Inc. / Colorado Springs Health Partners, SW
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Palm Springs Research Institute
mi
from
Hialeah, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
PMG Research of Hickory, LLC
mi
from
Hickory, NC
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Health Concepts
mi
from
Rapid City, SD
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Radiant Research, Inc
mi
from
San Antonio, TX
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Sundance Clinical Research, LLC
mi
from
St. Louis, MO
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically
Status: Enrolling, Phase I
Updated: 12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Biomarkers for Intestinal Permeability in Patients With Constipation
Status: Enrolling
Updated: 9/14/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Tennessee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
University Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gastroenterology, Neurology, Psychiatry / Psychology Clinical Trial
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Status: Enrolling, Phase
Updated: 12/31/1969
The Center for Autism & Neurodevelopmental Disorders
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
HealthStar Research, LLC
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Actca
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Methodist Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Preferred Primary Care Physicians, Inc
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
1 2 3 4 5 6 7 8